EDEM2
ER degradation-enhancing alpha-mannosidase-like protein 2
Also known as: bA4204.1, C20orf31, C20orf49, EDEM2_HUMAN, FLJ10783
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BV94
- Gene
- EDEM2
- Ensembl
- ENSG00000088298
- Chromosome
- 20
- Canonical length
- 578 aa
- Protein class
- Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This record represents naturally-occurring readthrough transcription between upstream GeneID:101410538 (MMP24 antisense RNA 1) and the ER degradation enhancing alpha-mannosidase like protein 2 (EDEM2) gene. Readthrough transcripts may encode proteins similar to those encoded by the EDEM2 gene. [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
578 residues, UniProt reviewed canonical sequence.
>Q9BV94|EDEM2
1 MPFRLLIPLG LLCALLPQHH GAPGPDGSAP DPAHYRERVK AMFYHAYDSY LENAFPFDEL
61 RPLTCDGHDT WGSFSLTLID ALDTLLILGN VSEFQRVVEV LQDSVDFDID VNASVFETNI
121 RVVGGLLSAH LLSKKAGVEV EAGWPCSGPL LRMAEEAARK LLPAFQTPTG MPYGTVNLLH
181 GVNPGETPVT CTAGIGTFIV EFATLSSLTG DPVFEDVARV ALMRLWESRS DIGLVGNHID
241 VLTGKWVAQD AGIGAGVDSY FEYLVKGAIL LQDKKLMAMF LEYNKAIRNY TRFDDWYLWV
301 QMYKGTVSMP VFQSLEAYWP GLQSLIGDID NAMRTFLNYY TVWKQFGGLP EFYNIPQGYT
361 VEKREGYPLR PELIESAMYL YRATGDPTLL ELGRDAVESI EKISKVECGF ATIKDLRDHK
421 LDNRMESFFL AETVKYLYLL FDPTNFIHNN GSTFDAVITP YGECILGAGG YIFNTEAHPI
481 DPAALHCCQR LKEEQWEVED LMREFYSLKR SRSKFQKNTV SSGPWEPPAR PGTLFSPENH
541 DQARERKPAK QKVPLLSCPS QPFTSKLALL GQVFLDSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EDEM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 42 nTPM
- liver: 37 nTPM
- pancreas: 32 nTPM
- spleen: 32 nTPM
- placenta: 26 nTPM
- bone marrow: 26 nTPM
Single-cell type
- extravillous trophoblasts: 212 nCPM
- syncytiotrophoblasts: 116 nCPM
- plasma cells: 95 nCPM
- cytotrophoblasts: 86 nCPM
- hofbauer cells: 84 nCPM
- migrating cytotrophoblasts: 82 nCPM
Immune cell
- myeloid DC: 101 nTPM
- classical monocyte: 97 nTPM
- total PBMC: 80 nTPM
- MAIT T-cell: 79 nTPM
- eosinophil: 76 nTPM
- non-classical monocyte: 73 nTPM
Brain region
- cerebellum: 23 nTPM
- thalamus: 22 nTPM
- choroid plexus: 18 nTPM
- medulla oblongata: 18 nTPM
- pons: 17 nTPM
- white matter: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.54
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carbohydrate metabolic process
- endoplasmic reticulum mannose trimming
- endoplasmic reticulum unfolded protein response
- ERAD pathway
- positive regulation of retrograde protein transport, ER to cytosol
- ubiquitin-dependent glycoprotein ERAD pathway
- viral protein processing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EDEM2 as an antibody target. Whether an autoantibody or antibody against EDEM2 could matter depends on whether native EDEM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EDEM2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EDEM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...